Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. KEGG DRUG DrugBank 薬物名（臨床試験情報から抽出） KEGG GENES KEGG PATHWAY 指定難病告示番号
1 Cyclophosphamide 💬1件: Cyclophosphamide6件: Ciclofosfamida; Ciclofosfamide; Cyclophosphamid; Cyclophosphamide; Cyclophosphamidum; Cytoxan--44件: 11, 13, 14, 16, 19, 20, 26, 28, 35, 36, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 52, 56, 60, 62, 65, 66, 84, 85, 93, 96, 162, 164, 172, 205, 222, 224, 256, 274, 283, 284, 285, 288, 326, 331 💬
2 Desmopressin 💬1件: Desmopressin5件: DDAVP; Desmopressin; Desmopressin acetate; Desmopressine; Minirin2件: AVPR2,
F8 💬 		4件: Complement and coagulation cascades, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬6件: 6, 64, 72, 75, 225, 288 💬
3 Simvastatin 💬1件: Simvastatin3件: Simvastatin; Simvastatina; Simvastatine1件: HMGCR 💬 4件: AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬21件: 6, 13, 15, 34, 46, 49, 51, 66, 79, 86, 89, 94, 158, 160, 162, 195, 265, 288, 298, 299, 310 💬
4 Prednisone 💬1件: Prednisone3件: PREDNISONA; Prednisone; RAYOS1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬45件: 2, 11, 13, 14, 19, 26, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 61, 63, 64, 65, 66, 79, 81, 84, 85, 86, 95, 96, 97, 113, 162, 164, 205, 222, 224, 228, 283, 284, 288, 299, 300, 307, 331 💬
5 Tranexamic acid 💬1件: Tranexamic acid1件: Tranexamic Acid1件: PLG 💬 4件: Complement and coagulation cascades, Influenza A, Neuroactive ligand-receptor interaction, Staphylococcus aureus infection 💬7件: 46, 70, 215, 227, 274, 288, 299 💬
6 Sodium chloride 💬1件: Sodium chloride6件: Lactated Ringers; Natriumchlorid; REBIF; Saline; Sodium chloride; Sporanox--20件: 6, 11, 13, 14, 34, 41, 46, 50, 51, 53, 60, 67, 70, 96, 168, 193, 227, 228, 288, 299 💬
7 Rituximab 💬1件: Rituximab6件: MabThera; Rituxan; Rituximab; Rixathon; Ruxience; Truxima1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬48件: 11, 13, 14, 19, 26, 35, 36, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 52, 53, 55, 56, 60, 61, 63, 64, 65, 66, 83, 84, 85, 86, 93, 94, 96, 97, 162, 222, 229, 256, 271, 274, 283, 284, 285, 288, 296, 300, 331 💬
8 Bortezomib 💬1件: Bortezomib3件: Bortezomib; Bortezomib Accord; Velcade1件: PSMB5 💬 8件: Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia 💬17件: 11, 13, 26, 28, 46, 49, 51, 61, 63, 64, 66, 222, 228, 256, 283, 288, 331 💬
9 Oprelvekin 💬1件: Oprelvekin5件: IL-11; Interleukin 11; Interleukin-11; Oprelvekin; Recombinant interleukin-111件: IL11RA 💬 3件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway 💬2件: 96, 288 💬
10 Cyclophosphamide 💬1件: Cyclophosphamide6件: Ciclofosfamida; Ciclofosfamide; Cyclophosphamid; CYCLOPHOSPHAMIDE; Cyclophosphamidum; Cytoxan--44件: 11, 13, 14, 16, 19, 20, 26, 28, 35, 36, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 52, 56, 60, 62, 65, 66, 84, 85, 93, 96, 162, 164, 172, 205, 222, 224, 256, 274, 283, 284, 285, 288, 326, 331 💬
11 Vonicog alfa 💬1件: Vonicog alfa3件: Veyvondi; VON WILLEBRAND FACTOR; VONICOG ALFA--1件: 288 💬
12 Catridecacog 💬1件: Catridecacog1件: Catridecacog--2件: 97, 288 💬
13 Rurioctocog alfa pegol 💬1件: Rurioctocog alfa pegol1件: Rurioctocog alfa pegol--1件: 288 💬
14 Emicizumab 💬1件: Emicizumab2件: Emicizumab; Hemlibra2件: F10,
F9 💬 		1件: Complement and coagulation cascades 💬1件: 288 💬
15 Susoctocog alfa 💬1件: Susoctocog alfa1件: OBIZUR--1件: 288 💬
16 Efanesoctocog alfa 💬1件: Efanesoctocog alfa1件: Efanesoctocog alfa--1件: 288 💬